BiosanaPharma Overview
- Year Founded
-
2012
- Status
-
Out of Business
- Employees
-
22
- Latest Deal Type
-
Out of Business
BiosanaPharma General Information
Description
Operator of a biopharmaceutical platform intended to focus on reducing the manufacturing costs of monoclonal antibody biological drugs. The company's platform engages in the development and production of monoclonal antibodies with a focus on biosimilars, enabling medical businesses to reach optimal profitability and improve the lives of patients.
Contact Information
Website
www.biosanapharma.comCorporate Office
- J.H. Oortweg 21
- 2333 CH Leiden
- Netherlands
Corporate Office
- J.H. Oortweg 21
- 2333 CH Leiden
- Netherlands
BiosanaPharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 11-Oct-2026 | Completed | Out of Business | |||
| 6. Secondary Transaction - Private | 01-Jan-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 03-Dec-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 01-Jan-2017 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 01-Dec-2015 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-Jan-2015 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Startup |
BiosanaPharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BiosanaPharma Patents
BiosanaPharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023228549-A1 | Continuous manufacturing of a biological substance with process traceability | Pending | 01-Mar-2022 | ||
| US-20250179417-A1 | Continuous manufacturing of a biological substance with process traceability | Pending | 01-Mar-2022 | ||
| WO-2023167584-A1 | Continuous manufacturing of a biological substance with process traceability | Inactive | 01-Mar-2022 | ||
| AU-2013341858-A1 | Discontinuous fed batch processing with the use of alternating bioreactors | Active | 09-Nov-2012 | ||
| AU-2013341858-B2 | Discontinuous fed batch processing with the use of alternating bioreactors | Inactive | 09-Nov-2012 | C12M47/10 |
BiosanaPharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BiosanaPharma Investments & Acquisitions (2)
BiosanaPharma’s most recent deal was a Merger/Acquisition with BiOraliX. The deal was made on 01-Jan-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BiOraliX | 01-Jan-2018 | Merger/Acquisition | Drug Delivery | ||
| BiOraliX | 01-Oct-2017 | Joint Venture | Drug Delivery |
BiosanaPharma FAQs
-
When was BiosanaPharma founded?
BiosanaPharma was founded in 2012.
-
Where is BiosanaPharma headquartered?
BiosanaPharma is headquartered in Leiden, Netherlands.
-
What is the size of BiosanaPharma?
BiosanaPharma has 22 total employees.
-
What industry is BiosanaPharma in?
BiosanaPharma’s primary industry is Machinery (B2B).
-
Is BiosanaPharma a private or public company?
BiosanaPharma is a Private company.
-
What is BiosanaPharma’s current revenue?
The current revenue for BiosanaPharma is .
-
How much funding has BiosanaPharma raised over time?
BiosanaPharma has raised $17M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
